Advance Ai

Advance AI provides a business-to-business Software-as-a-Service (SaaS) platform tailored for the pharmaceutical sector. Founded in 2023 and based in the United Kingdom, the company offers pharmaceutical leaders continuous, real-time visibility into the quality of conversations between their field-based teams and Health Care Professionals (HCPs). The service was developed in collaboration with IBM and utilizes artificial intelligence to observe, record, and analyze these interactions.

The platform converts conversation data into key performance indicators (KPIs) presented on daily-updated dashboards. These analytics deliver insights on campaign execution, the application of selling skills, and the outcomes of calls, enabling pharma companies to enhance the effectiveness of their sales and marketing strategies. Advance AI's business model is subscription-based, providing clients with access to its platform and analytical tools. The company's leadership includes CEO Garrett Mears and Chairman Gary Page, who brings experience from founding and selling STEM Healthcare.

Advance AI targets leading pharmaceutical companies, helping them to accelerate brand performance and gain a competitive advantage through data-driven insights. The technology is designed to be specific to the pharmaceutical industry, offering industry benchmarks and real-time feedback on in-field marketing campaigns. The company emphasizes ethical and responsible AI use, ensuring its solutions comply with industry regulations.

Keywords: pharmaceutical services, SaaS, conversation analysis, AI for pharma, field team performance, HCP engagement, sales force effectiveness, campaign execution analysis, healthcare professional interaction, real-time KPI dashboards, commercial excellence, pharmaceutical marketing, sales strategy, data-driven insights, IBM AI, medical affairs, brand performance, client engagement analytics, in-call outcomes